Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - vinblastine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - used in the treatment of hodgkins' disease (stages iii and iv) in combination therapy (with adriamycin, bleomycin and dacarbazine as abvd) and in the treatment of advanced testicular carcinoma (with cisplatin and bleomycin). in the palliative treatment of lymphocytic lymphoma, histiocytic lymphoma, kaposi's sarcoma and histiocytosis x. advanced stages of mycosis fungoides. may be used in the treatment of choriocarcinoma resistant to other chemotherapeutic agents; carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: water for injections; mannitol; sulfuric acid; sodium hydroxide - vincristine sulfate is indicated in acute leukaemia - current practices of cancer chemotherapy involve the simultaneous use of several agents. for enhanced therapeutic effect without additive toxicity, agents with different dose-limiting clinical toxicities and different mechanisms of action are generally selected. it is rarely possible to achieve equally good results with single agent treatment. thus vincristine sulfate is often chosen as part of polychemotherapy because of its unique clinical toxicity (neuropathy). see dosage and administration for possible increased toxicity when used in combination therapy. it has been shown to be useful in combination with other oncolytic agents in hodgkin's disease, non-hodgkin's malignant lymphomas (lymphocytic, mixed-cell, histiocytic, undifferentiated, nodular and diffuse types), rhabdomyosarcoma, neuroblastoma, wilm's tumour, osteogenic sarcoma, mycosis fungoides, ewing's sarcoma, carcinoma of the uterine cervix, breast cancer, malignant melanoma, oat-cell carcinoma

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - vincristine sulfate 1 mg/ml;  ;   - solution for injection - 1 mg/ml - active: vincristine sulfate 1 mg/ml     excipient: mannitol sodium hydroxide sulfuric acid water for injection

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sodium hydroxide; sulfuric acid - vincristine is used primarily in the treatment of acute leukaemia, usually as a component of various chemotherapeutic regimens. it has also been used as part of combination therapy in the treatment of hodgkin's disease, non-hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, wilm's tumour, osteogenic sarcoma, mycosis fungoides, ewing's sarcoma, carcinoma of the uterine cervix, breast cancer, malignant melanoma, oat-cell carcinoma of the lung and gynaecological tumours of childhood. vincristine may be useful in patients with true idiopathic thrombocytopenic purpura resistant to the usual treatment, but not recommended as primary treatment for this disorder

Namibja - Ingliż - Namibia Medicines Regulatory Council

cipla medpro (pty) ltd, south africa - bleomycin - powder for solution for injection - each vial contains bleomycin sulphate 7.5mg equivalent to 15units of bleomycion as a lyophilised solid powder

Kenja - Ingliż - Pharmacy and Poisons Board

cipla ltd cipla house, peninsula business park, ganpatrao - bleomycin sulfate usp - powder for injection - 15 units/vial - cytotoxic antibioticsand related substances:

Għarabja Sawdita - Ingliż - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

korea united pharm. inc, south korea - bleomycin sulfate - powder for solution for injection - 15 iu,

Ġappun - Ingliż - すりの適正使用協議会 RAD-AR Council, Japan

nippon kayaku - bleomycin sulfate - clear to pale yellow, translucent ointment

Kenja - Ingliż - Pharmacy and Poisons Board

zydus healthcare limited ackruti star, unit no. 103, midc, andheri (e), - bleomycin hcl for injection u.s.p. - powder for injection - bleomycin hcl for injection 15 units - cytotoxic antibioticsand related substances:

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

bleomycin sulfate -